中性粒细胞/淋巴细胞比值在接受再灌注治疗的缺血性卒中患者中的预测作用  

Predictive role of neutrophil to lymphocyte ratio in patients with ischemic stroke receiving reperfusion therapy

作　　者：王佳[1] 杨春晓[1] Wang Jia;Yang Chunxiao(Ward Six of Department of Neurology,the Second Affiliated Hospital of Harbin Medical University,Harbin 150000,China)

机构地区：[1]哈尔滨医科大学附属第二医院神经内科六病房,哈尔滨150000

出　　处：《国际脑血管病杂志》2021年第4期291-293,共3页International Journal of Cerebrovascular Diseases

摘　　要：卒中是世界范围内的主要死亡原因之一,其中85%以上为急性缺血性卒中,再灌注治疗是其主要治疗方法。研究表明,中性粒细胞/淋巴细胞比值(neutrophil-to-lymphocyte ratio,NLR)与再灌注治疗的有效性、安全性和转归相关。文章对NLR在接受再灌注治疗的缺血性卒中患者中的预测作用进行了综述。Stroke is one of the main causes of death in the world,of which more than 85%are acute ischemic stroke,and reperfusion therapy is its main treatment.Studies have shown that the neutrophil to lymphocyte ratio(NLR)is associated with the efficacy,safety and outcome of the reperfusion therapy.This article reviews the predictive role of NLR in patients with ischemic stroke receiving reperfusion therapy.

关 键 词：卒中 脑缺血 血栓溶解疗法 血管内手术 血栓切除术 中性粒细胞 淋巴细胞 试验预期值 

分 类 号：R743.3[医药卫生—神经病学与精神病学]